Cormorant Asset Management, LP - 10%+ Owner at Ambrx Biopharma Cayman, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
AMAM
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Cormorant Asset Management, LP since 11 Sep 2025

Reported holdings for Cormorant Asset Management, LP in Ambrx Biopharma Cayman, Inc.

Form 4 holding 10%+ Owner

Ambrx Biopharma Inc.

Security class
Ordinary Shares
Shares / value
69,465,823
Estimated value
$642,190,694
Report date
18 Sep 2023
Price
$9.24
Ownership
Indirect

Transaction history for Cormorant Asset Management, LP in Ambrx Biopharma Cayman, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .